Cm Beads 6FF Offers High Chemical Stability for CIP Protocols

Name: Cm Beads 6FF Offers High Chemical Stability for CIP Protocols
Brand: Changzhou Smart-Life Sciences Biotechnology Co., Ltd.
SKU: 2275822845

Jiangsu, ChinaChangzhou Smart-Life Sciences Biotechnology Co., Ltd.

US$30.00-400.00

1 Piece

Product specifications

Volume

Sample price:US$0.00/piece.Request sample

Product profile

Customization

Available

Classification

Biochemical Reagents

Content

Standard

Model NO.

CM Beads 6FF

Matrix Spherical

Highly Cross-Linked 6% Agarose

Ion Exchange Type

Weak Cation

Ion Exchange Capacity

0.09-0.13mmol H+/Ml Medium

Particle Size

45-165 μm

Flow Rate

300-600 Cm/H

pH Stability

4-13

Storage Buffer

1× Pbs Containing 20% Ethanol

Storage

4°C - 30°C

Transport Package

Cardboard Packaging

Specification

25ml/100ml/500ml

Trademark

Smart-Lifesciences

Origin

China

Company profile

High Repeat Buyers ChoiceSelf-brandedPatents AwardedManagement Certification

Changzhou Smart-Life Sciences Biotechnology Co., Ltd.

Jiangsu, China

Business Type: Manufacturer/Factory CertifiedR&D Capacity: ODM Service Available & OEM Service Available CertifiedCustomization Options: Customization from Samples, Customization from Designs, etc. CertifiedExport Year: 1 Year CertifiedNearest Port: Shanghai PortAverage Response Time: ≤9.22h

AI-Powered supplier vetting

SummaryThe supplier operates in biological technology and medical-device production and sales, including Class I, II, and III devices within stated license scopes. It offers 3D design, OEM, ODM, and several customization models, but reports no new products in the past year and no available SDK. Inventory and multiple quotation/payment options are available, with stated lead times within 15 workdays in both peak and off-season; however, no overseas warehouse or showroom is available, and there is no valid manufacturing-capacity contract with related subcontractors. Service governance is weak: no written procedures or records were reported for supplier-service assessment, corrective/preventive actions, or complaint handling. Finished products are checked by packing staff. The provided financial records show zero values, but no financial figures are included here.

Supplier typeThe supplier is positioned in biological technology and medical devices, covering technical research and development, technical services and transfer, production of raw materials for in-vitro diagnostic reagents, and production and sales of Class I, II, and III medical devices within stated license scopes. This supports classification as a medical-device and biotechnology supplier.

After-Sales capabilityThe supplier has inventory capability, accepts several service quotation and payment terms, and states lead times within 15 workdays in both peak and off-season. However, it reports no written procedures or records for effective supplier-service assessment, corrective/preventive actions, or customer-complaint handling, and has no overseas warehouse or showroom; these gaps weaken documented after-sales support.

Financial creditThe supplied financial and cash-flow slices report zero operating revenue, costs, profit, cash receipts, cash inflows, cash outflows, and current ratio for the stated periods. These records do not demonstrate financial strength or operating activity, creating a material credibility concern based on the provided data.

Customization capabilityThe supplier explicitly supports customization from samples, designs, full customization, minor customization, and flexible customization, alongside 3D design, ODM, and OEM services for known brands. These statements directly support broad customization capability.